Navigation Links
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Date:3/26/2009

eight and 55 percent are considered obese.(v) Data support that weight loss (even a modest amount) supports patients in their efforts to achieve and sustain glycemic control.(vi,vii)

About BYETTA(R) (exenatide) injection

BYETTA is the first and only FDA-approved incretin mimetic for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone glucagon like peptide-1 (GLP-1). GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain. BYETTA is approved by the FDA for use by people with type 2 diabetes who are unsuccessful at controlling their blood sugar levels. BYETTA is an add-on therapy for people currently using metformin, a sulfonylurea, or a thiazolidinedione. BYETTA provides sustained A1C control and low incidence of hypoglycemia when used with metformin or a thiazolidinedione, with potential weight loss. BYETTA is not a weight loss product. BYETTA was approved in April 2005 and has been used by more than one million patients since its introduction. For full prescribing information, visit www.BYETTA.com.

Important Safety Information for BYETTA

BYETTA improves glucose (blood sugar) control in adults with type 2 diabetes. It is used with metformin, a sulfonylurea, or a thiazolidinedione. BYETTA is not a substitute for insulin in patients whose diabetes requires insulin treatment. BYETTA is not recommended for use in patients with severe problems digesting food or those who have severe disease of the stomach or kidney.

When BYETTA is used with a medicine that contains a sulfonylurea, hypoglycemia (low blood sugar) is a possible side effect. To reduce this possibility, the dose of sulfonylurea medicine may need to be reduced while using BYETTA. Other common side effects with BYETTA include n
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. New Data From Head-to-Head Phase 3 Trial Demonstrate That Liraglutide is More Effective Than Exenatide in Treatment of Type 2 Diabetes
2. Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
8. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
9. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
10. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
11. Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... AudioNotch is the internet's leading provider of Notched ... tinnitus. Patients listen to sound therapy that is tailor-made ... weeks to months, their tinnitus volume decreases. , AudioNotch has ... and Notched White Noise. Now, AudioNotch is pleased to announce ...
(Date:1/14/2014)... a leading provider of strategic communications services to corporations and organizations ... the United States and Europe ... is returning to the firm,s Washington, D.C. ... than two years of service as Associate Commissioner for the Office ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility ... of Product Strategy. In this role, Michelle will work with ... guide in the development of iLab products. Her main goal ... benefit to the scientific community by offering the most advanced, ...
(Date:1/14/2014)... USA, and Cardiff, UK (PRWEB) January 13, 2014 ... technology development leader with more than 20 years in ... for optics and photonics . Hainsey will serve as ... delighted to have Dr. Hainsey join SPIE as our ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2
... Report the Use of Haptoglobin Typing,to Predict Cardiovascular ... MONTVALE, N.J., Nov. 10 Synvista,Therapeutics, Inc. ... Annual Scientific,Sessions of the American Heart Association, underway ... determine haptoglobin (Hp) genotype utilizing,intellectual property licensed from ...
... Nov. 10 SenesTech, Inc. has launched,the regulatory ... the first,ContraPest(R) product with the government of Australia. ... rice field rat species, registration,of ContraPest(R) bait will ... management product to the agricultural ministries of Southeast,Asia. ...
... with more than $500 million in ... cash - Conference ... ... ISIS ) today announced its financial results,for the third quarter ended September 30, 2008. Isis, ...
Cached Biology Technology:Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 2Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 3Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 4Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 5SenesTech, Inc. Commences Product Registration Process With Australian Government 2Isis Reports Financial Results and Highlights for Third Quarter of 2008 2Isis Reports Financial Results and Highlights for Third Quarter of 2008 3Isis Reports Financial Results and Highlights for Third Quarter of 2008 4Isis Reports Financial Results and Highlights for Third Quarter of 2008 5Isis Reports Financial Results and Highlights for Third Quarter of 2008 6Isis Reports Financial Results and Highlights for Third Quarter of 2008 7Isis Reports Financial Results and Highlights for Third Quarter of 2008 8Isis Reports Financial Results and Highlights for Third Quarter of 2008 9Isis Reports Financial Results and Highlights for Third Quarter of 2008 10Isis Reports Financial Results and Highlights for Third Quarter of 2008 11Isis Reports Financial Results and Highlights for Third Quarter of 2008 12Isis Reports Financial Results and Highlights for Third Quarter of 2008 13Isis Reports Financial Results and Highlights for Third Quarter of 2008 14Isis Reports Financial Results and Highlights for Third Quarter of 2008 15
(Date:4/17/2014)... Current Biology on April 17 have discovered ... Brazilian insects, which represent four distinct but related species ... example of an animal with sex-reversed genitalia. , ... animals, Neotrogla is the only example in ... Yoshizawa from Hokkaido University in Japan. , During copulation, ...
(Date:4/17/2014)... is the process whereby the genetic information of ... as proteins, which have numerous different functions in ... important intermediary during gene expression, by relating the ... involved in manufacturing proteins. , By examining ... present in an organism at a given time, ...
(Date:4/17/2014)... Pine forests are chock full of wild animals and ... populations of fungi are churning away in the soil, ... , Despite the vital role these fungi play in ... A Stanford-led team of scientists has generated a genetic ... North America. The work was published this week in ...
Breaking Biology News(10 mins):In sex-reversed cave insects, females have the penises 2Rapid and accurate mRNA detection in plant tissues 2Stanford biologists help solve fungal mysteries 2Stanford biologists help solve fungal mysteries 3
... Southwestern Medical Center challenge one of the established views ... Every time we move, feel emotions, think or remember, ... messages to one another via chemical signals called neurotransmitters. ... sequester neurotransmitters and release them when needed into the ...
... all in the packaging. How nature wraps and tags genes ... from Harvard and the Massachusetts Institute of Technology (M.I.T.). They ... protein structure that surrounds the human genome. , Their findings ... switched on during development of the human body and in ...
... older are as,inevitable and obvious as “going gray,?yet ... of this usually unwelcome transformation.,In a report posted ... Science,researchers from Dana-Farber Cancer Institute and Children’s Hospital,Boston ... graying hair while,investigating the origins of malignant melanoma, ...
Cached Biology News:New research questions basic tenet of neuron function 2Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 2Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 3Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones. 2Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones. 3
Anti-MT3-MMP Membrane-Type Metalloproteinase-3; propeptide domain; rabbit host...
Rabbit polyclonal to Methionine Aminopeptidase 2 ( Abpromise for all tested applications). entrezGeneID: 10988 SwissProtID: P50579...
Mouse monoclonal [TU-20] to beta III Tubulin (FITC) ( Abpromise for all tested applications). entrezGeneID: 10381 SwissProtID: Q13509...
Chlamydia pneumoniae (TWAR)...
Biology Products: